FI20060089A0 - Käyttäytymishäiriöiden hoito - Google Patents

Käyttäytymishäiriöiden hoito

Info

Publication number
FI20060089A0
FI20060089A0 FI20060089A FI20060089A FI20060089A0 FI 20060089 A0 FI20060089 A0 FI 20060089A0 FI 20060089 A FI20060089 A FI 20060089A FI 20060089 A FI20060089 A FI 20060089A FI 20060089 A0 FI20060089 A0 FI 20060089A0
Authority
FI
Finland
Prior art keywords
treatment
behavioral disorders
behavioral
disorders
Prior art date
Application number
FI20060089A
Other languages
English (en)
Swedish (sv)
Inventor
Heikki Matti Eemeli Rauvala
Juha Kuja-Panula
Vootele Voikar
Natalia Kulesskaya
Original Assignee
Heikki Matti Eemeli Rauvala
Juha Kuja-Panula
Vootele Voikar
Natalia Kulesskaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heikki Matti Eemeli Rauvala, Juha Kuja-Panula, Vootele Voikar, Natalia Kulesskaya filed Critical Heikki Matti Eemeli Rauvala
Priority to FI20060089A priority Critical patent/FI20060089A0/fi
Publication of FI20060089A0 publication Critical patent/FI20060089A0/fi
Priority to PCT/FI2007/050051 priority patent/WO2007085706A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9466Antidepressants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knock-out vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/035Animal model for multifactorial diseases
    • A01K2267/0356Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20060089A 2006-01-30 2006-01-30 Käyttäytymishäiriöiden hoito FI20060089A0 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20060089A FI20060089A0 (fi) 2006-01-30 2006-01-30 Käyttäytymishäiriöiden hoito
PCT/FI2007/050051 WO2007085706A1 (en) 2006-01-30 2007-01-30 Method for screening substances for treatment of neuropsychiatric diseases and materials therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20060089A FI20060089A0 (fi) 2006-01-30 2006-01-30 Käyttäytymishäiriöiden hoito

Publications (1)

Publication Number Publication Date
FI20060089A0 true FI20060089A0 (fi) 2006-01-30

Family

ID=35883898

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060089A FI20060089A0 (fi) 2006-01-30 2006-01-30 Käyttäytymishäiriöiden hoito

Country Status (2)

Country Link
FI (1) FI20060089A0 (fi)
WO (1) WO2007085706A1 (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241284A1 (en) * 2002-12-13 2006-10-26 Juha Kuja-Panula Transmembrane protein amigo and uses thereof
WO2005104834A2 (en) * 2004-04-14 2005-11-10 Euro-Celtique S.A. Pain-associated gene pnpg5

Also Published As

Publication number Publication date
WO2007085706A1 (en) 2007-08-02
WO2007085706A8 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
LTPA2016033I1 (lt) Fabri ligos gydymo priemonės
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
BRPI0812361A2 (pt) Derivados de pirazol heteroaril-substituídos úteis parao tratamento de distúrbios e doenças hiperproliferativos associados à angiogênese
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK1993589T3 (da) Behandlinger for neurologiske sygdomme
BRPI0716466A2 (pt) Tratamento da calda de açúcar
DK2035369T3 (da) Terapeutiske
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
HK1247943A1 (zh) 發育相關疾病的治療
FI20060995A0 (fi) Luonnollisen kielen käsittely
BRPI0715728A8 (pt) tratamento de distúrbios cartilaginosos
DK2173831T3 (da) Brøndbehandling
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
FI20065834A0 (fi) Iskulaite
GB0700972D0 (en) Treatment of inflammatory disease
DK2056858T3 (da) Behandling af lungesygdomstilstande
DK2099446T3 (da) Fremgangsmåde til behandling af inflammatorisk tarmsygdom
GB0720976D0 (en) Treatment of inflammatory disease
NO20070042L (no) Behandling av hydrokarboner

Legal Events

Date Code Title Description
FD Application lapsed